{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T04:00:29Z","timestamp":1763092829112},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,14]]},"DOI":"10.7759\/cureus.36156","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T01:16:37Z","timestamp":1678842997000},"source":"Crossref","is-referenced-by-count":1,"title":["Persistent Coagulopathy After Synthetic Cannabinoid Use"],"prefix":"10.7759","author":[{"given":"Mahvish","family":"Haider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Acevedo-Cajigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A","family":"Zorrilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1424","article-title":"\"Not for human consumption\": a review of emerging designer drugs","volume":"34","author":"Musselman ME","year":"2014","unstructured":"Musselman ME, Hampton JP. \"Not for human consumption\": a review of emerging designer drugs. Pharmacotherapy. 2014, 34:745-57. 10.1002\/phar.1424","journal-title":"Pharmacotherapy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807652","article-title":"An outbreak of synthetic cannabinoid-associated coagulopathy in Illinois","volume":"379","author":"Kelkar AH","year":"2018","unstructured":"Kelkar AH, Smith NA, Martial A, Moole H, Tarantino MD, Roberts JC. An outbreak of synthetic cannabinoid-associated coagulopathy in Illinois. N Engl J Med. 2018, 379:1216-23. 10.1056\/NEJMoa1807652","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.33176\/AACB-19-00029","article-title":"Superwarfarin (long-acting anticoagulant rodenticides) poisoning: from pathophysiology to laboratory-guided clinical management","volume":"40","author":"Chong YK","year":"2019","unstructured":"Chong YK, Mak TW. Superwarfarin (long-acting anticoagulant rodenticides) poisoning: from pathophysiology to laboratory-guided clinical management. Clin Biochem Rev. 2019, 40:175-85. 10.33176\/AACB-19-00029","journal-title":"Clin Biochem Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.587126","article-title":"Management of intentional superwarfarin poisoning with long-term vitamin K and brodifacoum levels","volume":"49","author":"Gunja N","year":"2011","unstructured":"Gunja N, Coggins A, Bidny S. Management of intentional superwarfarin poisoning with long-term vitamin K and brodifacoum levels. Clin Toxicol (Phila). 2011, 49:385-90. 10.3109\/15563650.2011.587126","journal-title":"Clin Toxicol (Phila)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2000.108317","article-title":"Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing","volume":"36","author":"Bruno GR","year":"2000","unstructured":"Bruno GR, Howland MA, McMeeking A, Hoffman RS. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med. 2000, 36:262-7. 10.1067\/mem.2000.108317","journal-title":"Ann Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.31482\/mmsl.2013.003","article-title":"Toxic potential of Superwarfarin: brodifacoum","volume":"82","author":"Pato\u010dka J","year":"2013","unstructured":"Pato\u010dka J, Petroianu G, Ku\u010da K. Toxic potential of Superwarfarin: brodifacoum. Milit Med Sci Lett. 2013, 82:32-8. 10.31482\/mmsl.2013.003","journal-title":"Milit Med Sci Lett"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2019.02.011","article-title":"The relative toxicity of brodifacoum enantiomers","volume":"306","author":"Feinstein DL","year":"2019","unstructured":"Feinstein DL, Gierzal K, Iqbal A, et al.. The relative toxicity of brodifacoum enantiomers. Toxicol Lett. 2019, 306:61-5. 10.1016\/j.toxlet.2019.02.011","journal-title":"Toxicol Lett"},{"key":"ref8","unstructured":"Restrictions on Rodenticide Products. (2022). Accessed. March 23, 2022: https:\/\/www.epa.gov\/rodenticides\/restrictions-rodenticide-products#types."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00162","article-title":"Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective","volume":"6","author":"Cohen K","year":"2018","unstructured":"Cohen K, Weinstein AM. Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective. Front Public Health. 2018, 6:162. 10.3389\/fpubh.2018.00162","journal-title":"Front Public Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000001002","article-title":"The public health response to a large poisoning outbreak involving an illicit substance: synthetic cannabinoids contaminated with a long-acting anticoagulant rodenticide, Illinois, March-July, 2018","volume":"26","author":"Navon L","year":"2020","unstructured":"Navon L, Moritz E, Austin C, Wahl M, Aks S, Layden J. The public health response to a large poisoning outbreak involving an illicit substance: synthetic cannabinoids contaminated with a long-acting anticoagulant rodenticide, Illinois, March-July, 2018. J Public Health Manag Pract. 2020, 26:E1-7. 10.1097\/PHH.0000000000001002","journal-title":"J Public Health Manag Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13085","article-title":"The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures","volume":"1374","author":"Feinstein DL","year":"2016","unstructured":"Feinstein DL, Akpa BS, Ayee MA, et al.. The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Ann N Y Acad Sci. 2016, 1374:111-22. 10.1111\/nyas.13085","journal-title":"Ann N Y Acad Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-018-0660-x","article-title":"Retrospective study of the characteristics of anticoagulant-type rodenticide poisoning in Hong Kong","volume":"14","author":"Ng WY","year":"2018","unstructured":"Ng WY, Ching CK, Chong YK, Ng SW, Cheung WL, Mak TW. Retrospective study of the characteristics of anticoagulant-type rodenticide poisoning in Hong Kong. J Med Toxicol. 2018, 14:218-28. 10.1007\/s13181-018-0660-x","journal-title":"J Med Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/24734306.2018.1500152","article-title":"Treatment for long acting anticoagulant rodenticide poisoning - beyond INR monitoring?","volume":"2","author":"Rubinstein I","year":"2018","unstructured":"Rubinstein I, Weinberg G, van Breemen R, Hershow RC, Feinstein DL. Treatment for long acting anticoagulant rodenticide poisoning - beyond INR monitoring?. Toxicol Commun. 2018, 2:59-61. 10.1080\/24734306.2018.1500152","journal-title":"Toxicol Commun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/136350-persistent-coagulopathy-after-synthetic-cannabinoid-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:43Z","timestamp":1707508483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/136350-persistent-coagulopathy-after-synthetic-cannabinoid-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.36156","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,14]]}}}